1-4 of 4
Hansjörg Schild
Close
Sort by
Journal Articles

Imatinib Mesylate and Nilotinib Affect the MHC-Class I Presentation by Modulating the Proteasomal Processing of Antigenic Peptides.

Stefanie Held, Stefan Tenzer, Thomas Rückrich, Karin von Schwarzenberg, Anita Bringmann, Annkristin Heine, Hansjörg Schild, Christoph Driessen, MD, Peter Brossart, MD
Journal: Blood
Blood (2009) 114 (22): 2169.
https://doi.org/10.1182/blood.V114.22.2169.2169
Published: 2009
Journal Articles

Mechanisms of Synergy Between Toll-Like Receptor 4 and Triggering Receptor Expressed on Myeloid Cells-1 in Human Neutrophils

Markus P Radsak, Hansjörg Schild, Philipp Haselmayer, Helmut R Salih, MD
Journal: Blood
Blood (2008) 112 (11): 3547.
https://doi.org/10.1182/blood.V112.11.3547.3547
Published: 2008
Journal Articles

Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo

Tobias Warger, Philipp Osterloh, Gerd Rechtsteiner, Melanie Fassbender, Valeska Heib, Beate Schmid, Edgar Schmitt, Hansjörg Schild, Markus P. Radsak
Journal: Blood
Blood (2006) 108 (2): 544–550.
https://doi.org/10.1182/blood-2005-10-4015
Published: 2006
Journal Articles

Human platelets express heat shock protein receptors and regulate dendritic cell maturation

Norbert Hilf, Harpreet Singh-Jasuja, Petra Schwarzmaier, Cécile Gouttefangeas, Hans-Georg Rammensee, Hansjörg Schild
Journal: Blood
Blood (2002) 99 (10): 3676–3682.
https://doi.org/10.1182/blood.V99.10.3676
Published: 2002